Pharmacologic studies proved that it can obviously inhibit blood platelet aggregation and showed hypolipemia activity. 藥理實(shí)驗(yàn)表明，具有顯著抑制血小板聚集、降血脂等功效。
Luo XP, Li Y, Fan WH, et al.Experimental study on reducing effects on Shexiang baoxin pill from damage of artery wall caused by hypolipemia[J]. 羅心平，李勇，范維琥，等.;麝香保心丸減少高脂血癥對(duì)動(dòng)脈壁損害作用的實(shí)驗(yàn)研究[J]
The main risk factors were smoking, hypertension, hyperlipemia or hypolipemia, family history of cerebrovascular disease, fat, drinking, TIA history, diabetes mellitus and atrial fibrillation, et al. 主要危險(xiǎn)因素有吸煙、高血壓、血脂異常、腦血管疾病家族史、肥胖、酗酒、TIA病史、糖尿病、房顫等。